• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无复流现象的经典与现代诊断方法的叙述性综述

A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon.

作者信息

Pantea-Roșan Larisa Renata, Bungau Simona Gabriela, Radu Andrei-Flavius, Pantea Vlad Alin, Moisi Mădălina Ioana, Vesa Cosmin Mihai, Behl Tapan, Nechifor Aurelia Cristina, Babes Elena Emilia, Stoicescu Manuela, Gitea Daniela, Iovanovici Diana Carina, Bustea Cristiana

机构信息

Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.

出版信息

Diagnostics (Basel). 2022 Apr 8;12(4):932. doi: 10.3390/diagnostics12040932.

DOI:10.3390/diagnostics12040932
PMID:35453980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9029120/
Abstract

The incidence of the no-reflow (NR) phenomenon varies depending on the diagnostic criteria used. If just the angiographic criteria are considered (i.e., a degree of thrombolysis in myocardial infarction ≤2), it will be found that the incidence of NR is quite low; on the other hand, when the myocardial NR is taken into account (i.e., a decrease in the quality of myocardial reperfusion expressed by the degree of myocardial blush), the real incidence is higher. Thus, the early establishment of a diagnosis of NR and the administration of specific treatment can lead to its reversibility. Otherwise, regardless of the follow-up period, patients with NR have a poor prognosis. In the present work, we offer a comprehensive perspective on diagnostic tools for NR detection, for improving the global management of patients with arterial microvasculature damage, which is a topic of major interest in the cardiology field, due to its complexity and its link with severe clinical outcomes.

摘要

无复流(NR)现象的发生率因所采用的诊断标准而异。如果仅考虑血管造影标准(即心肌梗死溶栓分级≤2级),会发现NR的发生率相当低;另一方面,当考虑心肌无复流时(即通过心肌 blush 分级表示的心肌再灌注质量下降),实际发生率更高。因此,早期诊断NR并给予特异性治疗可使其逆转。否则,无论随访期如何,NR患者的预后都很差。在本研究中,我们提供了关于NR检测诊断工具的全面观点,以改善对动脉微血管损伤患者的整体管理,由于其复杂性及其与严重临床结局的关联,这是心脏病学领域一个备受关注的主题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/8a104a257189/diagnostics-12-00932-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/d4400976db32/diagnostics-12-00932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/bef12dfe84a6/diagnostics-12-00932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/c2205f87a6ad/diagnostics-12-00932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/a16e65f63855/diagnostics-12-00932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/8a104a257189/diagnostics-12-00932-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/d4400976db32/diagnostics-12-00932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/bef12dfe84a6/diagnostics-12-00932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/c2205f87a6ad/diagnostics-12-00932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/a16e65f63855/diagnostics-12-00932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c1/9029120/8a104a257189/diagnostics-12-00932-g005.jpg

相似文献

1
A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon.无复流现象的经典与现代诊断方法的叙述性综述
Diagnostics (Basel). 2022 Apr 8;12(4):932. doi: 10.3390/diagnostics12040932.
2
Clinical significance of no-reflow in different stages of primary angioplasty among patients with acute myocardial infarctions.急性心肌梗死患者直接血管成形术不同阶段无复流现象的临床意义
Perfusion. 2016 May;31(4):300-6. doi: 10.1177/0267659115604891. Epub 2015 Sep 9.
3
The no-reflow phenomenon: State of the art.无复流现象:最新进展
Arch Cardiovasc Dis. 2015 Dec;108(12):661-74. doi: 10.1016/j.acvd.2015.09.006. Epub 2015 Nov 23.
4
Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.ST段抬高型心肌梗死后高危患者的识别:血管造影参数与磁共振参数的比较
Circ Cardiovasc Imaging. 2017 Jun;10(6):e005841. doi: 10.1161/CIRCIMAGING.116.005841.
5
Relationship between R-wave peak time and no-reflow in ST elevation myocardial infarction treated with a primary percutaneous coronary intervention.直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死中R波峰时间与无复流的关系
Coron Artery Dis. 2017 Jun;28(4):326-331. doi: 10.1097/MCA.0000000000000477.
6
No-reflow: incidence and detection in the cath-lab.无复流:在导管室的发生率和检测。
Curr Pharm Des. 2013;19(25):4564-75. doi: 10.2174/1381612811319250005.
7
Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention.直接经皮冠状动脉介入治疗急性心肌梗死后无复流的临床和操作预测因素。
World J Emerg Med. 2014;5(2):96-102. doi: 10.5847/wjem.j.issn.1920-8642.2014.02.003.
8
Relationship between plaque composition and no-reflow phenomenon following primary angioplasty in patients with ST-segment elevation myocardial infarction--analysis with virtual histology intravascular ultrasound.急性 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后无复流现象与斑块成分的关系--虚拟组织学血管内超声分析。
J Cardiol. 2009 Oct;54(2):205-13. doi: 10.1016/j.jjcc.2009.05.009. Epub 2009 Jun 21.
9
Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling.直接冠状动脉介入治疗后心肌再灌注的血管造影模式与心室重构
Coron Artery Dis. 2011 Nov;22(7):507-14. doi: 10.1097/MCA.0b013e32834a37ae.
10
In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study.替罗非班术中早期使用可能减少直接经皮冠状动脉介入治疗时无复流现象的发生。一项前瞻性随机研究。
Arq Bras Cardiol. 2016 Nov;107(5):403-410. doi: 10.5935/abc.20160149.

引用本文的文献

1
The Role of Myocardial Revascularization in Ischemic Heart Failure in the Era of Modern Optimal Medical Therapy.现代最佳药物治疗时代心肌血运重建在缺血性心力衰竭中的作用
Medicina (Kaunas). 2025 Aug 12;61(8):1451. doi: 10.3390/medicina61081451.
2
Complete Revascularization in NSTE-ACS and Multivessel Disease: Clinical Outcomes and Prognostic Implications.非ST段抬高型急性冠脉综合征合并多支血管病变的完全血运重建:临床结局及预后意义
Life (Basel). 2025 Aug 15;15(8):1299. doi: 10.3390/life15081299.
3
Risk Stratification in Acute Coronary Syndromes: The Systemic Immune-Inflammation Index as Prognostic Marker.

本文引用的文献

1
No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction.急性心肌梗死中的无复流现象以及体内胆固醇结晶与脂质核心相结合的情况。
Int J Cardiol Heart Vasc. 2022 Jan 11;38:100953. doi: 10.1016/j.ijcha.2022.100953. eCollection 2022 Feb.
2
Identification of Flow-Limiting Coronary Stenosis With PCS: A New Cost-Effective Index Derived From the Product of Corrected TIMI Frame Count and Percent Diameter Stenosis.用PCS识别血流限制性冠状动脉狭窄:一种源自校正的TIMI帧数与直径狭窄百分比乘积的具有成本效益的新指标。
Front Cardiovasc Med. 2021 Nov 4;8:718935. doi: 10.3389/fcvm.2021.718935. eCollection 2021.
3
急性冠状动脉综合征的风险分层:全身免疫炎症指数作为预后标志物
Med Sci (Basel). 2025 Aug 8;13(3):116. doi: 10.3390/medsci13030116.
4
Exploring the Intersection of Geophysics and Diagnostic Imaging in the Health Sciences.探索地球物理学与健康科学中诊断成像的交叉领域。
Diagnostics (Basel). 2024 Jan 8;14(2):0. doi: 10.3390/diagnostics14020139.
5
Usefulness of the Edmonton Frail Scale in Assessing the Impact of Heart Failure on Frailty.埃德蒙顿虚弱量表在评估心力衰竭对虚弱影响中的作用。
In Vivo. 2023 Jul-Aug;37(4):1857-1866. doi: 10.21873/invivo.13277.
6
Lipidomic Predictors of Coronary No-Reflow.冠状动脉无复流的脂质组学预测指标
Metabolites. 2023 Jan 3;13(1):79. doi: 10.3390/metabo13010079.
7
Hemorheological and Microcirculatory Relations of Acute Pancreatitis.急性胰腺炎的血液流变学与微循环关系
Metabolites. 2022 Dec 20;13(1):4. doi: 10.3390/metabo13010004.
8
Myocardial Viability Testing in the Management of Ischemic Heart Failure.缺血性心力衰竭管理中的心肌存活检测
Life (Basel). 2022 Nov 1;12(11):1760. doi: 10.3390/life12111760.
The No-reflow Phenomenon: Is it Predictable by Demographic factors and Routine Laboratory Data?
无复流现象:它可以通过人口统计学因素和常规实验室数据预测吗?
Acta Biomed. 2021 Nov 3;92(5):e2021297. doi: 10.23750/abm.v92i5.10053.
4
Pleotropic Effects of Polyphenols in Cardiovascular System.多酚对心血管系统的多效作用。
Biomed Pharmacother. 2020 Oct;130:110714. doi: 10.1016/j.biopha.2020.110714. Epub 2020 Sep 28.
5
Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon.冠状动脉无复流现象的病理生理学、诊断与管理
Int J Angiol. 2021 Mar;30(1):15-21. doi: 10.1055/s-0041-1725979. Epub 2021 Mar 3.
6
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
Int J Surg. 2021 Apr;88:105906. doi: 10.1016/j.ijsu.2021.105906. Epub 2021 Mar 29.
7
Diagnostic accuracy of stress-only myocardial perfusion SPECT improved by deep learning.深度学习提高了仅应激心肌灌注 SPECT 的诊断准确性。
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2793-2800. doi: 10.1007/s00259-021-05202-9. Epub 2021 Jan 29.
8
State of the Art: No-Reflow Phenomenon.现状:无复流现象。
Cardiol Clin. 2020 Nov;38(4):563-573. doi: 10.1016/j.ccl.2020.07.001. Epub 2020 Sep 17.
9
No-Reflow after PPCI-A Predictor of Short-Term Outcomes in STEMI Patients.直接经皮冠状动脉介入治疗后无复流——ST段抬高型心肌梗死患者短期预后的预测因素
J Clin Med. 2020 Sep 12;9(9):2956. doi: 10.3390/jcm9092956.
10
No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case-control study (NORM PPCI).ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后无复流现象及与正常血流人群的比较:病例对照研究(NORM PPCI)
Open Heart. 2020 Jul;7(2). doi: 10.1136/openhrt-2019-001215.